Filing Details

Accession Number:
0001615774-17-003462
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-30 20:55:24
Reporting Period:
2017-06-30
Filing Date:
2017-06-30
Accepted Time:
2017-06-30 20:55:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180469 Ernest Mario C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2017-06-30 6,105 $4.28 5,895 No 4 S Indirect By Ernest and Mildred Mario Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Ernest and Mildred Mario Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 63,073 Direct
Footnotes
  1. The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $4.327801965601966. The range of sale prices on the transaction date was $4.25 to $4.29 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.